Unknown NA INTERVENTIONAL 3-arm NCT05059782

Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer

Sponsor: Xi'an Jiaotong University

Conditions Cancer of Ovary Cancer of the Ovary Cancer, Ovarian Cancer, Ovarian Stromal Cancers, Ovarian Cancers, Ovary Neoplasm, Ovarian Neoplasm, Ovary Neoplasms, Ovarian Neoplasms, Ovary Ovarian Cancer Ovarian Cancers Ovarian Neoplasm Ovary Cancer Ovary Cancers Ovary Neoplasm Ovary Neoplasms

Interventions IFRT, IMRT or SBRT chemotherapy, targeted therapeutics, immunotherapy

Updated 5 times since 2021 Last updated: Sep 25, 2021 Started: Oct 10, 2021 Primary completion: Feb 28, 2023 Completion: Sep 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cancer of Ovary and Cancer of the Ovary and is currently ongoing. Xi'an Jiaotong University leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Feb 2025 — Present [monthly]

Unknown NA
Oct 2024 — Feb 2025 [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Oct 2024 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Oct 2021 — Jul 2024 [monthly]

Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xi'an Jiaotong University

Data source: Xi'an Jiaotong University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Xi'an, China